Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
August 2, 2022
Patent Application Number
17135528
Date Filed
December 28, 2020
Patent Citations Received
Patent Primary Examiner
Disclosed is a pharmaceutical composition in dry powder form for intranasal administration, having an anti-anaphylactic adrenergic receptor agonist in the form of dry powder for intranasal administration, the composition having solid particles of the active agent in combination with at least one functional additive, and solid particles of an inert carrier.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
